With the as-constructed electrochemical immunosensor, the LC3+ EVs levels in actual samples, including tumor cell supernatants, peripheral blood from tumor-bearing (TB) mouse models, and breast cancer patients were determined. The gene discussed is MAP1LC3A; the disease is breast carcinoma.